| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |